Skip to content

Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment

Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment: Clinical and Radiological Outcome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05075148
Acronym
KOA-RI
Enrollment
20
Registered
2021-10-12
Start date
2021-01-01
Completion date
2022-03-30
Last updated
2021-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Cysts

Keywords

Radiology, Interventional, Epidemiology, Vascualr embolisation, Percutaneous alcoholization, Aneurysmal bone cyst

Brief summary

This study aims to describe the clinical outcomeand the radiological appearance of aneurysmal bone cyst treated by means of interventional radiology procedures (percutaneous sclerosis and endovascular embolization)

Interventions

OTHERradiology

Interventional radiology for aneurysmal bone cyst ( percutaneous alcoholization, vascualr embolisation)

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male of female * Aging from 0 to 30 years * With typical aneurysmal bone cyst at initial imaging * At least one interventional radiology procedure performed

Exclusion criteria

* No initial surgery * Patient refuses to participate

Design outcomes

Primary

MeasureTime frameDescription
Difference of size lesion after treatementday 1Percentage of peripheral reossification after treatment : * 0%: no reossification * \< 25%: low reossification * Between 25% -50%: Partial reossification * Between 50-75%: significant reossification * \> 75%: very significant reossification * 100%: complete reossifcation

Secondary

MeasureTime frameDescription
Number of painday 1Pain measured with Pain scale ( 0 = no pain , 10 = maximum pain)
number of deficienceday 1Number of patients needs second treatment 3- Fracture ? (yes or no)
number of complicationday 1Fracture ? (yes or no)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026